Alain Priour

Introduction

Alain Priour, based in Paris, France, is an accomplished inventor with a remarkable portfolio that includes five patents. His work primarily focuses on the development of novel crystalline forms intended to enhance pharmaceutical efficacy and treat bacterial infections.

Latest Patents

Among his recent innovations is a groundbreaking patent regarding the "Crystalline forms of trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide sodium salt." This invention outlines new crystalline forms of the sodium salt of trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide, referred to as NXL-104. Furthermore, the patent discusses compositions that combine these crystalline forms with antibacterial agents such as ceftaroline fosamil. Not only does it elaborate on processes for preparing these crystalline forms, but it also describes methods of treating bacterial infections using these compositions.

Career Highlights

Alain Priour has contributed significantly to the field of pharmaceuticals and has collaborated with various organizations during his career. He has worked with Forest Laboratories Holdings Limited, which highlights his experience in a corporate environment enhancing his inventive capabilities.

Collaborations

Throughout his career, Alain has collaborated with notable colleagues, including Alain Bonnet and Mahendra G Dedhiya. These partnerships have likely contributed to the breadth of his experience and knowledge within the pharmaceutical industry, particularly in the realm of innovative drug development.

Conclusion

Alain Priour is a distinguished inventor whose patents are instrumental in advancing pharmaceutical science. His innovative approaches to developing crystalline forms of antibiotic compounds not only promise to enhance treatment efficiency but also reflect the ongoing evolution within the pharmaceutical field. His contributions serve as a testament to the creative potential inherent in scientific research and collaboration.